Investing

Top Analyst Upgrades and Downgrades: Amazon, Clovis, Glaukos, Hertz, Peabody, Whiting and More

Jon C. Ogg

Stocks were marginally higher on Monday morning on a day where markets are looking for directional news ahead of a deep week of corporate earnings. The trend that has held up is that investors have bought into every stock market dip for almost 4 years now. 24/7 Wall St. reviews dozens of analyst reports each day of the week to find new trading and new investing ideas for its readers. Some of these analyst calls cover stocks to buy, while some of these analyst calls cover stocks to sell or stocks to avoid.

These are this Monday’s top analyst upgrades, downgrades and initiations.

Amazon.com Inc. (NASDAQ: AMZN) has seen two analyst upgrades: Wedbush raised its rating to Outperform from Neutral and raised its target to $575 from $435, and Cowen raised its rating to Outperform from Market Perform and lifted the price target to $565 from $435.

Clovis Oncology Inc. (NASDAQ: CLVS) was reiterated as Buy at Goldman Sachs, but the firm added it to the prized Conviction Buy List with a $110 price target (versus an $87.06 close).

Glaukos Corp. (NYSE: GKOS) saw its analyst quiet period end and was started as follows: Cantor Fitzgerald at Buy, Goldman Sachs at Neutral, JPMorgan at Overweight and William Blair at Outperform.

Hertz Global Holdings Inc. (NYSE: HTZ) was started as Outperform at Credit Suisse with a $23 price target (versus a $19.01 close) and reiterated as Reduce at Morgan Stanley, despite last week’s gains.

Peabody Energy Corp. (NYSE: BTU) was maintained as Buy but the price target was cut to $6 from $9 at Citigroup. This was after an 8% drop to $1.29 on Friday.

Whiting Petroleum Corp. (NYSE: WLL) was raised to Positive from Neutral with a price target of $33.00 (versus a $26.47 close) at Susquehanna. Shares were indicated up over 1% at $26.80 on Monday morning.

ALSO READ: Why Bank of America and Citigroup Book Value Discount Matters

Yelp Inc. (NYSE: YELP) was downgraded to Equal Weight from Overweight at Barclays, and the price target was cut to $36 from $50 in the call. Shares were indicated down 1% or so from the $34.96 closing price.

Other key analyst upgrades and downgrades were in the following: